APA aipamena

Kälin, R., Mastrella, G., Hou, M., Li, M., Stoecklein, V., Zdouc, N., . . . Glass, R. (2019). ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA. Neuro Oncol.

Chicago Style aipamena

Kälin, Roland, et al. "ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA." Neuro Oncol 2019.

MLA aipamena

Kälin, Roland, et al. "ANGI-03. PHARMACOLOGICAL TARGETING OF APELIN/APLNR SIGNALING BLUNTS THERAPY RESISTANCE TO VEGFA/VEGFR2 ANTI-ANGIOGENIC TREATMENT IN GLIOBLASTOMA." Neuro Oncol 2019.